BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25319385)

  • 1. Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial.
    Masson S; Caironi P; Fanizza C; Thomae R; Bernasconi R; Noto A; Oggioni R; Pasetti GS; Romero M; Tognoni G; Latini R; Gattinoni L
    Intensive Care Med; 2015 Jan; 41(1):12-20. PubMed ID: 25319385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial.
    Masson S; Caironi P; Spanuth E; Thomae R; Panigada M; Sangiorgi G; Fumagalli R; Mauri T; Isgrò S; Fanizza C; Romero M; Tognoni G; Latini R; Gattinoni L;
    Crit Care; 2014 Jan; 18(1):R6. PubMed ID: 24393424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock.
    Masson S; Caironi P; Fanizza C; Carrer S; Caricato A; Fassini P; Vago T; Romero M; Tognoni G; Gattinoni L; Latini R;
    Crit Care Med; 2016 Apr; 44(4):707-16. PubMed ID: 26571184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial.
    Caironi P; Masson S; Mauri T; Bottazzi B; Leone R; Magnoli M; Barlera S; Mamprin F; Fedele A; Mantovani A; Tognoni G; Pesenti A; Gattinoni L; Latini R;
    Eur J Clin Invest; 2017 Jan; 47(1):73-83. PubMed ID: 27864924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.
    Behnes M; Bertsch T; Lepiorz D; Lang S; Trinkmann F; Brueckmann M; Borggrefe M; Hoffmann U
    Crit Care; 2014 Sep; 18(5):507. PubMed ID: 25190134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock: Data From the Albumin Italian Outcome Sepsis Study.
    Røsjø H; Masson S; Caironi P; Stridsberg M; Magnoli M; Christensen G; Moise G; Urbano MC; Gattinoni L; Pesenti A; Latini R; Omland T;
    Crit Care Med; 2018 May; 46(5):e404-e410. PubMed ID: 29481425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study.
    Ulla M; Pizzolato E; Lucchiari M; Loiacono M; Soardo F; Forno D; Morello F; Lupia E; Moiraghi C; Mengozzi G; Battista S
    Crit Care; 2013 Jul; 17(4):R168. PubMed ID: 23899120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department.
    Liu B; Chen YX; Yin Q; Zhao YZ; Li CS
    Crit Care; 2013 Oct; 17(5):R244. PubMed ID: 24138799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presepsin Values Predict Septic Acute Kidney Injury, Acute Respiratory Distress Syndrome, Disseminated Intravascular Coagulation, and Shock.
    Shimoyama Y; Umegaki O; Kadono N; Minami T
    Shock; 2021 Apr; 55(4):501-506. PubMed ID: 32925599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of plasma presepsin levels in determining the incidence of septic shock and mortality in patients with sepsis.
    Kahveci U; Ozkan S; Melekoglu A; Usul E; Ozturk G; Cetin E; Abatay K; Sahin A
    J Infect Dev Ctries; 2021 Jan; 15(1):123-130. PubMed ID: 33571154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Value of Presepsin Guidance in Shortening Antibiotic Therapy in Septic Patients: a Multicenter, Prospective Cohort Trial.
    Xiao H; Wang G; Wang Y; Tan Z; Sun X; Zhou J; Duan M; Zhi D; Tang Z; Hang C; Zhang G; Li Y; Wu C; Li F; Zhang H; Wang J; Zhang Y; Zhang X; Guo W; Qi W; Xie M; Li C
    Shock; 2022 Jan; 57(1):63-71. PubMed ID: 34618727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presepsin as a predictor of septic shock in patients with urinary tract infection.
    Sekine Y; Kotani K; Oka D; Nakayama H; Miyazawa Y; Syuto T; Arai S; Nomura M; Koike H; Matsui H; Shibata Y; Murakami M; Suzuki K
    BMC Urol; 2021 Oct; 21(1):144. PubMed ID: 34641833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Value of Presepsin in Comparison to hsCRP as a Monitoring and Early Prognostic Marker for Sepsis in Critically Ill Patients.
    Hassan EA; Abdel Rehim AS; Ahmed AO; Abdullahtif H; Attia A
    Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30717340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: a prospective observational study according to the Sepsis-3 definitions.
    Lee S; Song J; Park DW; Seok H; Ahn S; Kim J; Park J; Cho HJ; Moon S
    BMC Infect Dis; 2022 Jan; 22(1):8. PubMed ID: 34983420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of presepsin as diagnostic and prognostic marker of sepsis in daily clinical practice.
    Jereb M; Mavric M; Skvarc M; Drobnic A; Dolenc S; Strunjas NP; Luksic B; Kmet NG
    J Infect Dev Ctries; 2019 Nov; 13(11):1038-1044. PubMed ID: 32087076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
    Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
    Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin replacement in patients with severe sepsis or septic shock.
    Caironi P; Tognoni G; Masson S; Fumagalli R; Pesenti A; Romero M; Fanizza C; Caspani L; Faenza S; Grasselli G; Iapichino G; Antonelli M; Parrini V; Fiore G; Latini R; Gattinoni L;
    N Engl J Med; 2014 Apr; 370(15):1412-21. PubMed ID: 24635772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Biologically Active Adrenomedullin (bio-ADM) Predicts Hemodynamic Support Requirement and Mortality During Sepsis.
    Caironi P; Latini R; Struck J; Hartmann O; Bergmann A; Maggio G; Cavana M; Tognoni G; Pesenti A; Gattinoni L; Masson S;
    Chest; 2017 Aug; 152(2):312-320. PubMed ID: 28411114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis.
    Ali FT; Ali MA; Elnakeeb MM; Bendary HN
    Clin Chim Acta; 2016 Sep; 460():93-101. PubMed ID: 27353646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presepsin and prognostic nutritional index are predictors of septic acute kidney injury, renal replacement therapy initiation in sepsis patients, and prognosis in septic acute kidney injury patients: a pilot study.
    Shimoyama Y; Umegaki O; Kadono N; Minami T
    BMC Nephrol; 2021 Jun; 22(1):219. PubMed ID: 34118899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.